Legal & General Group
ATYR

Legal & General Group’s aTyr Pharma ATYR Stock Holding History

Legal & General Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.18K Sell
7,920
-1,650
-17% -$1.39K ﹤0.01% 3261
2025
Q4 		$7.49K Hold
9,570
– – ﹤0.01% 3302
2025
Q3 		$6.9K Hold
9,570
– – ﹤0.01% 3341
2025
Q2 		$48.5K Buy
+9,570
New +$37.7K ﹤0.01% 2712

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group's ATYR Position: Q1 2026 in Review

Legal & General Group reduced its aTyr Pharma (ATYR) stake by 17% in Q1 2026, selling an estimated $1.39K and leaving 7,920 shares worth $6.18K. The position accounts for ﹤0.01% of the portfolio, ranked #3261.

Legal & General Group first reported a position in ATYR in Q2 2025 and has held it in 4 quarters since. The position peaked at $48.5K in Q2 2025. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • Legal & General Group held 7,920 shares of aTyr Pharma worth $6.18K as of Q1 2026.
  • Legal & General Group sold 1,650 aTyr Pharma shares in Q1 2026, an estimated $1.39K.
  • aTyr Pharma made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3261 holding.
  • Legal & General Group first reported a position in aTyr Pharma in Q2 2025 and has held it in 4 quarters since.
  • Legal & General Group's aTyr Pharma position peaked at $48.5K in Q2 2025.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.